Oppenheimer analyst Steven Lichtman lowered the price target on DexCom (NASDAQ: DXCM) to $105.00 (from $525.00) while maintaining an Outperform ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst EPS View Analyst PT Change

DexCom Tumbles 12% After Earnings Miss, Analysts Say Plunge 'Greatly Exaggerated'July 29, 2022 9:19 AM DexCom (DXCM) PT Lowered to $92 at BTIGJuly 29, 2022 6:01 AM DexCom (DXCM) PT Lowered to $112 at StifelJuly 29, 2022 3:25 AM After-Hours Movers: Amazon, Apple Gain Post EPS; Roku, Intel PlungeJuly 28, 2022 6:05 PM Form 10-Q DEXCOM INC For: Jun 30July 28, 2022 5:16 PM Form 8-K DEXCOM INC For: Jul 26July 28, 2022 4:24 PM Form 8-K DEXCOM INC For: Jul 28July 28, 2022 4:08 PM DexCom (DXCM) Misses Q2 EPS by 2cJuly 28, 2022 4:04 PM Dexcom Reports Second Quarter 2022 Financial ResultsJuly 28, 2022 4:03 PM